Diclofenac Potassium | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Diclofenac Potassium
Health Canada Patents

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Diclofenac Potassium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 11 USDMF, 6 CEP/COS, 4 EU WC, 1 KDMF, 6 NDC API, 18 Listed Suppliers, $ API Reference Price

30 API Suppliers
11 USDMF
6 CEP/COS
4 EU WC
1 KDMF
6 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

159 FDF Dossiers, 27 FDA Orange Book, 67 Europe, 5 Canada, 8 South Africa, 52 Listed Dossiers

159 FDF Dossiers
27 FDA Orange Book
67 Europe
5 Canada
8 South Africa
52 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 25MG

TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - 25MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 18 SPI Pharma, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 1 Avesta Pharma, 25 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 1 Gloria Interchem, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 44 Coating Systems & Additives, 39 Direct Compression, 34 Disintegrants & Superdisintegrants, 33 Granulation, 30 Taste Masking, 26 Solubilizers, 26 Thickeners and Stabilizers, 24 Parenteral, 22 Controlled & Modified Release, 20 Film Formers & Plasticizers, 20 Chewable & Orodispersible Aids, 17 Topical, 15 Co-Processed Excipients, 15 Lubricants & Glidants, 9 Empty Capsules, 8 Emulsifying Agents, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

73 Fillers, Diluents & Binders
44 Coating Systems & Additives
39 Direct Compression
34 Disintegrants & Superdisintegrants
33 Granulation
30 Taste Masking
26 Solubilizers
26 Thickeners and Stabilizers
24 Parenteral
22 Controlled & Modified Release
20 Film Formers & Plasticizers
20 Chewable & Orodispersible Aids
17 Topical
15 Co-Processed Excipients
15 Lubricants & Glidants
9 Empty Capsules
8 Emulsifying Agents
6 Surfactant & Foaming Agents
6 API Stability Enhancers
5 Rheology Modifiers
4 Vegetarian Capsules
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 1 Regulatory FDF Prices

18 US Medicaid Prescriptions
1 Regulatory FDF Prices

MARKET PLACE

22 APIs, 5 FDF Dossiers

22 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 2 Health Canada Patents

10 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

1 EDQM
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 17 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Aralez Pharmaceuticals Canada Inc

02 1Riches, McKenzie & Herbert LLP

filter Patent Reset all filters

2 All

01 12254144

02 12932603

filter Product Reset all filters

2 All

01 2Diclofenac Potassium

filter Dosage Reset all filters

2 All

01 2Powder for oral solution

filter Exp Date Reset all filters

2 All

01 12017-05-15

02 12026-06-16

Product Main Page

01

Aralez Pharmaceuticals Canad...

Diclofenac Potassium

BioProcess International US West

Not Confirmed

Aralez Pharmaceuticals Canada Inc

Country

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-06-16

Date Granted : 2017-08-08

Diclofenac Potassium

Brand Name : CAMBIA

Patent Number : 2932603

Filing Date : 2006-06-16

Strength per Unit : 50 mg / sachet

Dosage Form : Powder for oral solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-06-16

Date Granted : 2017-08-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Riches, McKenzie & Herbert L...

Diclofenac Potassium

BioProcess International US West

Not Confirmed

Riches, McKenzie & Herbert LLP

Country

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Diclofenac Potassium

Brand Name : CAMBIA

Patent Number : 2254144

Filing Date : 1997-05-15

Strength per Unit : 50 mg / sachet

Dosage Form : Powder for oral solution

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-05-15

Date Granted : 2007-11-20

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.